Few studies on Colombian breast/ovarian cancer cases have reported a yield of PVs of 11% to 22% on selected cases based on international criteria and using multigene cancer panels (25 to 143 genes), with BRCA1/2 genes contributions between 7.2% to 17.6% [31–33]. This evidence concerns the gene BRCA1 and cancer.